MCC
MDGL icon

Money Concepts Capital’s Madrigal Pharmaceuticals MDGL Stock Holding History

Money Concepts Capital’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,258
Closed -$789K – 433
2023
Q1 		$789K Buy
3,258
+1,329
+69% +$362K 0.04% 248
2022
Q4 		$560K Hold
1,929
– – 0.03% 403
2022
Q3 		$125K Buy
+1,929
New +$134K 0.01% 529
2022
Q2 		– Sell
-37
Closed -$4K – 2143
2022
Q1 		$4K Buy
+37
New +$3.12K ﹤0.01% 2284

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Money Concepts Capital's MDGL Position: Q2 2023 in Review

Money Concepts Capital sold out of Madrigal Pharmaceuticals (MDGL) in Q2 2023, closing a stake of 3,258 shares — an estimated $789K sold.

Money Concepts Capital first reported a position in MDGL in Q1 2022 and held it in 4 quarters. The position peaked at $789K in Q1 2023. 208 funds tracked by Wall St. Rank hold MDGL as of Q2 2023.

  • Money Concepts Capital reported no remaining Madrigal Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Money Concepts Capital sold 3,258 Madrigal Pharmaceuticals shares in Q2 2023, an estimated $789K.
  • Money Concepts Capital first reported a position in Madrigal Pharmaceuticals in Q1 2022 and held it in 4 quarters.
  • Money Concepts Capital's Madrigal Pharmaceuticals position peaked at $789K in Q1 2023.
  • 208 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2023.

Based on Money Concepts Capital's 13F filing for Q2 2023, filed 1 Aug 2023.